| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/08/2005 | US20050196800 a Thermus aquaticus DNA polymerase mutant and a template nucleic acid molecule; low fidelity mutants useful for introducing mutations into specific genes due to increased frequency of misincorporation of nucleotides; high fidelity mutants useful for PCR amplification of genes and mapping genetic mutation |
| 09/08/2005 | US20050196799 Use of representations of DNA for genetic analysis |
| 09/08/2005 | US20050196798 Nucleoside triphosphate diphosphohydrolase (NTPDASE 8) and uses thereof |
| 09/08/2005 | US20050196797 PI-3-kinase-related kinase polypeptide for use as tool in identifying modulators for prevntion and treatment of cell proliferation disorders |
| 09/08/2005 | US20050196796 Compositions and methods for prognosis, diagnosis, prevention and treatment of cancers |
| 09/08/2005 | US20050196795 Using macrophage migration inhibitory factor (MIF) concentration as diagnostic/prognostic tool in detection and prevention of cell proliferative disorders of urogenital systems; antitumor agents |
| 09/08/2005 | US20050196794 Use of haplotypes and SNPs in lipid-relevant genes for the analysis and diagnosis of cardiovascular disease |
| 09/08/2005 | US20050196793 Using aberrant expression of caudal type homeobox transcription factor 2 (CDX2) as diagnostic indicator of stomach or esophageal cell proliferative disorers |
| 09/08/2005 | US20050196792 Analysis of methylation status using nucleic acid arrays |
| 09/08/2005 | US20050196790 Using probe specific hybridization and fluoresence to identify apoptosis-resistant cells |
| 09/08/2005 | US20050196789 Preparation of biologically derived fluids for biomarker determination by mass spectrometry |
| 09/08/2005 | US20050196788 isolated bacterial oxidase, comprising an oxidase that regenerates NADP+, NAD+, or both; isolated from Lactobacillus |
| 09/08/2005 | US20050196787 Antisense agents for use in treatment of diabetes and controlling blood lipid levels; gene expression inhibition |
| 09/08/2005 | US20050196786 Using mass tag complex as tool in monitoring transcriptional patterns of a plurality of biological molecules; diagnosing infection, cell proliferative, inflammator and developmental disorers |
| 09/08/2005 | US20050196785 Microarray for monitoring gene expression patterns; bioinformatics; genomics |
| 09/08/2005 | US20050196784 Using polymorphism in potassium channel interacting protein (KChIP1) as diagnostic indicator for pancreatic disorders |
| 09/08/2005 | US20050196782 Universal amplification of fragmented RNA |
| 09/08/2005 | US20050196781 RNA interference mediated inhibition of STAT3 gene expression using short interfering nucleic acid (siNA) |
| 09/08/2005 | US20050196778 Nucleic acid analysis apparatus |
| 09/08/2005 | US20050196776 Multicompartment apparatus which utilizes variation in electrical potential as tool in low cost and reliable detection of polymer hybridization |
| 09/08/2005 | US20050196775 Thermally, photochemically, and chemically stable in thin films and soluble in organic solvents; photovoltaic devices; sensors; semiconductors |
| 09/08/2005 | US20050196773 Predicting upper aerodigestive tract cancer |
| 09/08/2005 | US20050196771 Characterization of CYP 2D6 genotypes |
| 09/08/2005 | US20050196770 Methods for genetic analysis |
| 09/08/2005 | US20050196769 Preparing DNA from paraffin-embedded, formalin-fixed tissue samples for promoter methylation analysis by deparaffinizing the samples; boiling them in citrate buffer; and extracting DNA from them; hypermethylation of ATM gene promoter correlates with decreased overall head & neck cancer survival |
| 09/08/2005 | US20050196768 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 09/08/2005 | US20050196766 Producing variant lipid acyltransferase for enhancing fatty acid transfer between phosphatidylcholine and cholesterol |
| 09/08/2005 | US20050196765 siNA molecule comprising a double-stranded structure that down-regulates expression of checkpoint Kinase-1 (CHK-1), wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 09/08/2005 | US20050196764 Using amplification of expressed sequence tags as non-invasive method for diagnosis, prognosis and monitoring of genetic and infectious disease in humans and animals |
| 09/08/2005 | US20050196763 Using amplification of expressed sequence tags as non-invasive method for diagnosis, prognosis and monitoring of genetic and infectious disease in humans and animals |
| 09/08/2005 | US20050196762 Using amplification of expressed sequence tags as non-invasive method for diagnosis, prognosis and monitoring of genetic and infectious disease in humans and animals |
| 09/08/2005 | US20050196761 Multicomponent device for for helping to separate a microarray slide from a substrate backing |
| 09/08/2005 | US20050196760 Using pseudo monoplex amplification to generate preferential nucleotides; biochips |
| 09/08/2005 | US20050196759 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 09/08/2005 | US20050196757 Orphan receptor for idenifying modulators for treatment and prevention cell proliferative disorders; immunodiagnostics |
| 09/08/2005 | US20050196756 Simultaneously detecting mutually diffferent nucleotide sequences in a sample via multiplex polymerase chain reaction |
| 09/08/2005 | US20050196754 Nucleotide sequences coding modified immunoglobulin for use in immunodiagnostics and therapy |
| 09/08/2005 | US20050196753 Human coactivator-associated arginine methyltransferase 1 (hCARM1) |
| 09/08/2005 | US20050196752 Genomic sequence of the 5-Lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma |
| 09/08/2005 | US20050196751 Receptor protein is capable of activating transcription of desired gene when in presence of agonist and when bound to antagonist; gene therapy; gene expression inhibition; transgenic cells, animals |
| 09/08/2005 | US20050196750 Bioassay which utilizes invasive cleavage to identify single nucleotide polymorphism; genotyping and organismal classification |
| 09/08/2005 | US20050196748 Blood is drawn through a passageway, such as a catheter, past or against an obstruction or irregularity in the passageway, such as a wire placed in the catheter; platelets adhere and aggregate on the obstruction or on the wall of the passageway near the obstruction or irregularity, form a platelet mass |
| 09/08/2005 | US20050196747 Analyte test system for determining the concentration of an analyte in a physiological or aqueous fluid |
| 09/08/2005 | US20050196746 High-density ion transport measurement biochip devices and methods |
| 09/08/2005 | US20050196744 Method of screening cocaine antagonists |
| 09/08/2005 | US20050196743 Drug screening for modulator of heterologous receptors coupled to pheromone response pathway in yeast; identification of specific agonists and antagonists of G protein-coupled receptors; binding secreted protein to support; incubating with detector molecule conjugated with reporter; high speed |
| 09/08/2005 | US20050196412 Vaccine; components, parts, fragments and derivatives, genetic sequences; development of diagnostic and therapeutic compositions for treatment and prophylaxis of AIDS and related disorders; attenuating pathogenic strains of HIV-1 by mutagenizing particular regions of the HIV-1 genome; low risk |
| 09/08/2005 | US20050196409 Compositions of botanical extracts for treating malignancy-associated changes |
| 09/08/2005 | US20050196406 Which display a passenger polypeptide on the outer surface of a biological entity; displayed passenger polypeptide is capable of interacting or binding with a given ligand |
| 09/08/2005 | US20050196405 Pneumococcal surface protein c (pspc), epitopic regions and strain selection thereof, and uses therefor |
| 09/08/2005 | US20050196398 Nucleotide sequences coding specialized hydrolase for use as tool in identifying modulator for prevention and treatment of nervous system disorders; enzyme inhibitors |
| 09/08/2005 | US20050196392 Lesion repair polymerase compositions |
| 09/08/2005 | US20050195684 Apparatus and method for mixing specimens in vials |
| 09/08/2005 | US20050194251 Biosensor |
| 09/08/2005 | US20050194250 Sensor arrangement and method for operating a sensor arrangement |
| 09/08/2005 | DE10393473T5 Trap-Tagging: ein neuartiges Verfahren zur Identifikation und Reinigung von RNA-Protein-Komplexen Trap tagging: a novel method for the identification and purification of RNA-protein complexes |
| 09/08/2005 | DE10393248T5 Verfahren zum Feststellen von Mikroorganismen oder Zellen A method of detecting micro-organisms or cells |
| 09/08/2005 | DE10235967B4 Methode zum Identifizieren von Substanzen mit antimikrobieller Wirkung Method for identifying substances with antimicrobial activity |
| 09/08/2005 | DE102004007983A1 Testelement mit Einschicht-Reaktionsfilm Test element with single-reaction film |
| 09/07/2005 | EP1571226A2 Gene chip technology for determining memory genes |
| 09/07/2005 | EP1571225A1 Diagnosis of a disease and monitoring of therapy using the AC133 gene |
| 09/07/2005 | EP1571216A2 Phosphodiesterase 8A |
| 09/07/2005 | EP1571214A2 Immunogenic detoxified mutant toxin |
| 09/07/2005 | EP1571210A1 Method for analyzing variation of nucleic acid mutation and method for analyzing gene expression |
| 09/07/2005 | EP1571209A1 Method of detecting target base sequence of rna interference, method of designing polynucleotide base sequence causing rna interference, method of constructing double-stranded polynucleotide, method of regulating gene expression, base sequence processing apparatus, program for running base sequence |
| 09/07/2005 | EP1571158A2 Globular assembly of amyloid beta protein and uses thereof |
| 09/07/2005 | EP1570271A2 Waveguide system for detection of fluorescently labeled nucleic acid sequences |
| 09/07/2005 | EP1570250A2 Screening, quantitation and identification of active ingredients in natural products |
| 09/07/2005 | EP1570235A2 Compositions and methods used for identifying factors required for the agglomeration of proteins |
| 09/07/2005 | EP1570091A1 Method for electronically detecting at least one specific interaction between probe molecules and target biomolecules |
| 09/07/2005 | EP1570090A2 A biological sample storage device and method for biological sample contamination testing |
| 09/07/2005 | EP1570089A1 Molecules inhibiting hepatitis c virus protein synthesis and method for screening same |
| 09/07/2005 | EP1570086A2 Quantitative test for bacterial pathogens |
| 09/07/2005 | EP1570085A2 Method for in vitro selection of 2'-substituted nucleic acids |
| 09/07/2005 | EP1570084A1 Methods for identifying functionally related genes and drug targets |
| 09/07/2005 | EP1570083A2 Identification of genes involved in angiogenesis, and development of an angiogenesis diagnostic chip to identify patients with impaired angiogenesis |
| 09/07/2005 | EP1570081A2 Amplified genes involved in cancer |
| 09/07/2005 | EP1570080A1 Gene expression profiling of egfr positive cancer |
| 09/07/2005 | EP1570079A1 Multiplex assay detection of pathogenic organisms |
| 09/07/2005 | EP1570078A2 Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers |
| 09/07/2005 | EP1570077A1 Method for purifying nucleic acids |
| 09/07/2005 | EP1570076A1 Method and kit for detecting a risk for diabetes or a metabolic syndrome |
| 09/07/2005 | EP1570075A2 Method for determing predisposition to manifestation of immune system related diseases |
| 09/07/2005 | EP1570074A1 Genotyping of deafness by oligonucleotide microarray analysis |
| 09/07/2005 | EP1570072A1 Eukaryotic biosensor making use of a calcium regulated light emitting enzyme |
| 09/07/2005 | EP1570071A2 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 09/07/2005 | EP1570070A1 Method for the detection of pathogenic gram positive bacteria selected from the genera staphylococcus, enterococcus and streptococcus |
| 09/07/2005 | EP1570069A2 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 09/07/2005 | EP1570068A1 Process control based on analysis of microbial populations |
| 09/07/2005 | EP1570063A1 New expression system from rhodococcus |
| 09/07/2005 | EP1570061A2 Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide |
| 09/07/2005 | EP1570053A2 Methods and apparatus for whole cell panning |
| 09/07/2005 | EP1570051A2 Genetic constructs and compositions comprising rre and cte and uses thereof |
| 09/07/2005 | EP1570045A2 Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using |
| 09/07/2005 | EP1570043A2 Device and method for in-line blood testing using biochips |
| 09/07/2005 | EP1569956A2 Glycogen synthase kinase-3 inhibitors |
| 09/07/2005 | EP1569950A2 Plasmodium falciparum antigens and methods of use |
| 09/07/2005 | EP1569695A2 Antisense modulation of apolipoprotein b expression |
| 09/07/2005 | EP1569675A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 09/07/2005 | EP1569633A2 Ca ix-specific inhibitors |